In Regeneron Pharmaceuticals Inc.’s phase I/II Chord study of 12 children with genetic hearing loss tied to the variants of the otoferlin gene, 10 out of 11 have showed notable improvements in their ...

BioCity Biopharma’s selective endothelin receptor type A (ETA) antagonist has reduced excess proteins in the urine of ...

A minimally invasive therapy that has the potential to transform treatment of a common cause of high blood pressure, has been developed by researchers at UCL, Queen Mary University of London and Barts ...

Kyushu University researchers have uncovered a surprising layer of complexity in aldosterone-producing adenomas ...

As Wall Street looks ahead to phase III data due soon with Mineralys Therapeutics Inc.’s lorundrostat for uncontrolled or resistant hypertension, analysts are also weighing the odds of the firm in ...

Fukuoka, Japan - Kyushu University researchers have uncovered a surprising layer of complexity in aldosterone-producing adenomas (APAs)—adrenal gland ...

Kyushu University researchers have uncovered a surprising layer of complexity in aldosterone-producing adenomas ...

Researchers have uncovered a surprising layer of complexity in aldosterone-producing adenomas—adrenal gland tumors that drive ...

S L E is a chronic multisystem autoimmune disease in which cardiovascular disease is a leading cause of mortality, with a ...

Endoscopic ultrasound-guided radiofrequency ablation can offer an effective alternative to traditional surgery in treating ...

Scientists have developed a new type of CT scan that can detect tiny nodules in the adrenal glands, which are responsible for ...

Discover how a new method for high blood pressure treatment eliminates the need for traditional surgery while improving ...